Out-of-pocket payments for treatment of COVID-19 in Iran.

COVID-19 Coronavirus Hospital Out-of-pocket payment

Journal

Cost effectiveness and resource allocation : C/E
ISSN: 1478-7547
Titre abrégé: Cost Eff Resour Alloc
Pays: England
ID NLM: 101170476

Informations de publication

Date de publication:
19 Mar 2022
Historique:
received: 19 10 2021
accepted: 10 03 2022
entrez: 20 3 2022
pubmed: 21 3 2022
medline: 21 3 2022
Statut: epublish

Résumé

Out-of-pocket (OOP) is among the payment methods in Iran's health system. The present study aimed to examine the OOP treatment costs for patients with COVID-19 in Iran. A descriptive-analytical, cross-sectional study was conducted in 2021. In this study, the cost records of 550 patients with COVID-19 hospitalized in a referral center of COVID-19 were selected using the stratified random sampling method. The required data were collected using a researcher-made questionnaire. Data were analyzed by t-test, ANOVA, and Pearson's correlation coefficient in SPSS software version 23 at p = 0.05. The total direct costs were 1,037,992.15 US $. Moreover, the shares of patients (OOP), basic insurance, government subsidy, supplementary insurance, discounts, and out-of-government subsidy in the total direct costs were US $ 92,231.21, 746,932.99 US $, 155,127.08 US $, 39,690.25 US $ and 4010.61 US $, respectively. In addition, the results confirmed that there was a positive and significant relationship between the patients' OOP payments and the length of stay. It also found that the patients' OOP payments are subject to the type of insurance program and discharge method. According to the results, 8.89% of the total direct costs were directly paid out of the patients' pockets. The research findings confirm the urgent need to make decisions and implement effective interventions for COVID-19 disease by controlling risk factors and exploiting other countries' successful experiences and international organizations' recommendations to decrease the prevalence of the infected and consequently reduce the financial pressure of the disease on patients by approving the expansion of the insurance organizations' role.

Identifiants

pubmed: 35305664
doi: 10.1186/s12962-022-00350-7
pii: 10.1186/s12962-022-00350-7
pmc: PMC8934129
doi:

Types de publication

Journal Article

Langues

eng

Pagination

12

Informations de copyright

© 2022. The Author(s).

Références

Nature. 2020 Mar;579(7798):270-273
pubmed: 32015507
Iran J Public Health. 2012;41(9):62-70
pubmed: 23193508
BMC Public Health. 2016 Sep 15;16:992
pubmed: 27633253
medRxiv. 2021 Jun 18;:
pubmed: 34159340
Health Policy. 2012 Oct;107(2-3):276-88
pubmed: 22867940
Appl Health Econ Health Policy. 2011;9(1):39-49
pubmed: 21174481
J Pak Med Assoc. 2016 Nov;66(11):1401-1406
pubmed: 27812056
JAMA Netw Open. 2021 Oct 1;4(10):e2129894
pubmed: 34661662
J Epidemiol Glob Health. 2020 Sep;10(3):192-193
pubmed: 32954706
J Am Coll Surg. 2000 Aug;191(2):123-30
pubmed: 10945354
Eur J Health Econ. 2010 Oct;11(5):437-47
pubmed: 19756796
J Gerontol B Psychol Sci Soc Sci. 2003 Jan;58(1):S2-10
pubmed: 12496303
Health Policy. 2007 Feb;80(2):297-307
pubmed: 16678296
J Med Econ. 2021 Jan-Dec;24(1):308-317
pubmed: 33555956
Am J Prev Med. 2020 Sep;59(3):445-448
pubmed: 32703700
Bull World Health Organ. 2021 Feb 01;99(2):112-124
pubmed: 33551505
Iran J Pharm Res. 2016 Summer;15(3):567-571
pubmed: 27980593
Autoimmun Rev. 2006 Oct;5(8):511-6
pubmed: 17027884
BMC Health Serv Res. 2021 Feb 11;21(1):132
pubmed: 33573650
Cost Eff Resour Alloc. 2020 Jun 29;18:20
pubmed: 32612458
Am J Crit Care. 2006 Sep;15(5):502-9
pubmed: 16926372
Int J Health Care Finance Econ. 2011 Dec;11(4):267-85
pubmed: 21915727
Lancet. 2020 Mar 7;395(10226):764-766
pubmed: 32105609
BMC Health Serv Res. 2013 Jan 10;13:14
pubmed: 23305251
Clin Neurol Neurosurg. 2002 Jul;104(3):272-5
pubmed: 12127667
BMC Public Health. 2011 Mar 08;11:150
pubmed: 21385404
Health Policy. 2005 Dec;75(1):18-39
pubmed: 16298226
Int J Equity Health. 2008 Jun 09;7:15
pubmed: 18541025
Nature. 2020 Mar;579(7798):265-269
pubmed: 32015508
Lancet. 2001 Sep 8;358(9284):833-6
pubmed: 11564510

Auteurs

Ali Reza Yusefi (AR)

Department of Public Health, School of Health, Jiroft University of Medical Sciences, Jiroft, Iran.

Gholamhossein Mehralian (G)

School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran. gmehralian@gmail.com.

Abdolvahed Khodamoradi (A)

Department of Health Policy and Economics, Social Security Research Institute, Tehran, Iran.

Roghaye Abbasi (R)

Student Research Committee, School of Health, Jiroft University of Medical Sciences, Jiroft, Iran.

Fatemeh Vatankhah (F)

Student Research Committee, School of Health, Jiroft University of Medical Sciences, Jiroft, Iran.

Fatemeh Heaidari (F)

Student Research Committee, School of Health, Jiroft University of Medical Sciences, Jiroft, Iran.

Peivand Bastani (P)

Faculty of Health and Behavioral Sciences, School of Dentistry, University of Queensland, Brisbane, QLD, 4072, Australia.

Classifications MeSH